US Stocks
/
Immunocore Holdings plc Share Price
Immunocore Holdings plc Share Price

Immunocore Holdings plc Share Price

NASDAQ: IMCR | Small Cap
$29.39
+$0.27 (0.93%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immunocore Holdings plc Stock Performance

Open
$29.03
Prev. Close
$29.12
Circuit Range
N/A
Day Range
$29.03 - $29.72
Year Range
$27.59 - $40.40
Volume
47,344
Average Traded
$29.46

Immunocore Holdings plc Share Price Today

As of 10 October 2026, Immunocore Holdings plc's share price is $29.39. The stock opened at $29.03, compared to its previous close of $29.12. During today's trading session, Immunocore Holdings plc's share price traded between $29.03 and $29.72, with an average price of $29.38. Over the past 52 weeks, the stock has recorded a high of $40.40 and a low of $27.59. In terms of performance, Immunocore Holdings plc's share price has risen by 4.89% over the last six months and is down 10.74% on a year-on-year basis.

Immunocore Holdings plc Share Price Chart

$29.03$29.72
L
Show Current Price
H

Immunocore Holdings plc Stock Fundamentals & Key Indicators

Market Cap
$1.48B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.35
Revenue (TTM)
$400.02B
Return On Equity (TTM)
-4.31%
Profit Margin
-8.88%
Debt to Equity
0.94
Quarterly Earnings Growth YoY
-350.00%

Immunocore Holdings plc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$103.69$104.48$106.68$115.93
Net Profit-$0.18-$30.06$12.97-$0.81
Net Profit Margin-0.17%-28.77%12.16%-0.70%
Income ChangeN/A-16600.00%143.15%-106.25%

Immunocore Holdings plc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$174.36$249.43$310.20$400.02
Net Profit-$52.54-$55.29-$51.09-$35.51
Net Profit Margin-30.13%-22.17%-16.47%-8.88%
Income ChangeN/A-5.23%7.60%30.50%

About Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Immunocore Holdings plc Historical Returns

MonthOpenCloseChange %
Oct 2026
$30.27
$29.45
-2.76%
Sep 2026
$35.85
$30.29
-17.65%
Aug 2026
$33.91
$36.77
+8.82%
Jul 2026
$31.88
$33.80
+6.47%
Jun 2026
$28.29
$31.74
+10.09%
May 2026
$27.72
$28.83
+2.89%
Apr 2026
$31.02
$28.02
-7.00%
Mar 2026
$31.93
$30.13
-6.83%
Feb 2026
$32.29
$32.34
-0.64%
Jan 2026
$34.62
$32.55
-5.98%
Dec 2025
$39.00
$34.62
-12.02%
Nov 2025
$32.81
$39.35
+19.51%

IMCR Share Price FAQs

What is Immunocore Holdings plc share price today?

chevron-up
Immunocore Holdings plc share price today is $29.39 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Immunocore Holdings plc stock?

chevron-up
The 52 week high of Immunocore Holdings plc stock is $40.40, while the 52 week low is $27.59 as of 10 Oct '26.

What is IMCR's market capitalisation today?

chevron-up
IMCR market capitalisation is $1.48B as of October 10, 2026, at 4:41 am IST.

What is IMCR's net income for the last quarter?

chevron-up
IMCR's net income for the last quarter is -0.81B USD.

What is the 5 year returns of IMCR?

chevron-up
The 5 year returns of IMCR is -23.70% as on 10 Oct '26.

What is the high & low stock price of IMCR today?

chevron-up
IMCR stock price hit a high of $29.72 and low of $29.03 as of 10 Oct '26.

Can I buy IMCR shares in India?

chevron-up
Yes. You can buy IMCR in India by opening an international trading account.